PROSTATE CANCER PROGRAM

前列腺癌计划

• 批准号: 7506398
• 负责人: ERIC J SMALL
• 金额: $ 6.49万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-09-25 至 2012-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7506398
• 关键词: Area; Biology; Biomedical Engineering; Budgets; Chemicals; Clinical; Decision Making; Development; Diagnosis; Discipline; Disease Progression; Early Diagnosis; Environmental Risk Factor; Epidemiology; Faculty; Genetic; Goals; Health Resources; Image; Interdisciplinary Study; Intervention; Life; Malignant neoplasm of prostate; Medical; Outcomes Research; Peer Review; Prevention; Publications; Research; Risk; Risk Assessment; Scientist; Staging; Translating; Work; base; cancer epidemiology; carcinogenesis; improved; men; novel; novel therapeutics; programs; therapeutic target; tumor progression

The Prostate Cancer Program comprises 24 basic and clinical scientists from several disciplines, including 9 Departments working together to translate research into advances in the epidemiology, prevention, staging and treatment of prostate cancer. Program faculty represent membership in 4 graduate programs: PIBS, BMS, Bioengineering, and Chemical Biology. The goals of the Prostate Cancer program are to promote interdisciplinary research that will allow a better understanding of the biology of prostate cancer, from the biologic and environmental factors associated with carcinogenesis, early detection and disease progression to prognostication and the biologic basis of disease progression. The ultimate goal is the development of novel intervention strategies that will improve the lives of men who carry a diagnosis of prostate cancer or who are at risk of developing prostate cancer. The Prostate Cancer Program pursues these goals through ongoing work in five major thematic areas: (1) Prostate Cancer Epidemiology; (2) Imaging and Risk Assessment Strategies; (3) Genetics and Biology of Cancer Progression; (4) Outcomes Research, Health Resource Utilization and Medical Decision Making; and (5) Novel Therapeutic Targets and Approaches. The Program has $7,248,631 Total peer reviewed support for the last budget year. The Program has 26% intraprogrammatic and 23% inter-programmatic publications.

前列腺癌项目由来自多个学科的24名基础和临床科学家组成，其中包括9个部门，他们共同努力将研究转化为流行病学，预防，分期和治疗方面的进展。 和前列腺癌的治疗项目教师代表4个研究生项目的成员：PIBS， BMS，生物工程和化学生物学。前列腺癌的治疗方法有哪些？ 跨学科的研究，这将使更好地了解前列腺癌的生物学，从生物和环境因素与致癌，早期发现和疾病进展 以及疾病进展的生物学基础。最终目标是发展 新的干预策略，将改善患有前列腺癌或有患前列腺癌风险的男性的生活。前列腺癌计划通过以下方式实现这些目标： 目前正在五个主要专题领域开展工作：（1）前列腺癌流行病学;（2）成像和风险 评估策略;（3）癌症进展的遗传学和生物学;（4）结果研究，健康 资源利用和医疗决策;（5）新的治疗靶点和方法。的 该方案在上一个预算年度的同行审议支助总额为7，248，631美元。该方案有26%的方案内 和23%的跨计划出版物。